期刊文献+

犬肾去交感神经对长期快速心房起搏后心房基质和心房颤动诱发的影响 被引量:22

Effect of renal sympathetic denervation on the atrial substrate and inducibility of atrial fibrillation in ambulatory canines of prolonged atrial pacing
下载PDF
导出
摘要 目的探讨犬肾去交感神经对长期快速右房起搏后心房基质和心房颤动(AF)诱发的影响。方法 20只犬分为假手术组(n=6)、右房起搏(RAP)组(n=7)和肾去交感神经(RSD)组(n=7)三组。假手术组植入起搏器后程控关闭起搏器;RSD组先行双侧肾交感神经消融,经6周恢复后植入起搏器;RAP组和RSD组快速起搏(400~450次/分)右房5周。所有犬在试验开始时和终点进行血压测量及电生理检测;处死动物后迅速取左房组织,检测组织心房利钠肽(ANP)、血管紧张素Ⅱ(AngⅡ)和醛固酮水平,及组织半胱天冬酶-3(Caspase-3)、Bax、B淋巴细胞瘤-2基因(Bcl-2)、金属蛋白酶组织抑制剂-1(TIMP-1)、基质金属蛋白酶-9(MMP-9)和转化生长因子-β1(TGF-β1)等蛋白表达。结果 RSD组犬肾动脉消融6周后(植入起搏器前)收缩压较消融前显著降低(P=0.001);右房起搏5周后RSD组和RAP组的收缩压和舒张压较假手术组均明显降低(P<0.05),且RSD组收缩压较RAP组更低(P=0.036)。与假手术组和RSD组相比,RAP组起搏5周后诱发的AF持续时间明显延长(P<0.05)。RAP组心房有效不应期(AERP)明显缩短(P=0.002),而RSD组AERP的缩短无显著性(P=0.087)。与假手术组比较,RAP组犬左房的ANP、AngⅡ和醛固酮水平显著升高,而在RSD组其升高的趋势明显减缓(P<0.05)。与RAP组相比,RSD组犬左房的Caspase-3、Bax、MMP-9和TGF-β1蛋白表达显著降低,而Bcl-2和TIMP-1蛋白表达显著升高。结论肾去交感神经可抑制长期快速右房起搏后AF的诱发和心房基质改变。 Objective To investigate the effect of renal sympathetic denervation (RSD)on the atrial substrate and in- ducibility of atrial fibrillation (AF) after prolonged atrial pacing in ambulatory canines. Methods Twenty dogs were im- planted with a high frequency cardiac pacemaker, and were divided into three groups: sham-operated group (n = 6), right atrial pacing(RAP) group (n=7) and RSD group (n= 7). Sham-operated group dogs were only implanted with pacemak- ers without pacing. In RSD group dogs, a pacemaker was implanted 6 weeks after RSD was performed bilaterally for recov- ery. Atrial pacing was maintained for 5 weeks in both RAP group and RSD group. Electrophysiological test was measured in all the animals at the baseline and endpoint of the protocol. Then the heart was quickly excised and tissue specimens were obtained from the left atrium. The tissue levels of ANP, angiotensin 11 and aldosterone were examined by ELISA, and the exnression levels of Caspase-3. Bax, Bcl-2, TIMP-1, MMP-9 and TGF-131 were examined by western blotting. ResultsSystolic blood pressure was significantly decreased after RSD for 6 weeks in RSD group (P=0. 001 ). Similarly, systolic blood pressure was decreased after RAP for a mean of 5 weeks in the RAP group and the RSD group (P〈0. 05). Compared with the sham-operated group and RSD group, RAP group dogs had longer duration of AF induced by SI S1 programmed stimulation after 5 week atrial pacing(P〈0. 05 ). AERP was significantly shortened after prolonged atrial pacing from 142±8 ms to 115±9 ms in RAP group (P =0.002). However, the probability value that AERP decreased from 140±10 ms to 127±11ms in RSD group was not sig- nificantly different ( P = 0. 087). The tissue levels of ANP, angiotensin 11 and aldosterone increased significantly in RAP group, but the increasing trend was significantly inhibited in RSD group ( P〈0. 05). The expression levels of Caspase-3, Bax, MMP-9 and TGF-[31 in atrial tissue were significantly decreased, while the expression levels of Bcl-2 and TIMP-1 were increased in RSD group than that of RAP group (P〈0. 05). Conclusion Catheter-based renal denervation can re- duce the inducibility of AF and suppress atrial substrate by prolonged RAP.
出处 《中国心脏起搏与心电生理杂志》 2013年第5期431-435,共5页 Chinese Journal of Cardiac Pacing and Electrophysiology
基金 中央高校基本科研业务费专项资金资助(2012302020210) 国家科技支撑计划项目(2011BAI11B12) 国家自然科学基金(81070144)
关键词 心血管病学 心房颤动 肾交感神经 消融 肾素-血管紧张素-醛固酮系统 Cardiology Atrial fibrillation Renal sympathetic nerve Ablation Renin-angiotensin-aldosterone system Canine
  • 相关文献

参考文献15

  • 1Iravanian S, Dudley SC, The Renin-Angiotensin-Aldosterone System (RAAS) and Cardiac Arrhythmias [ J ]. Heart Rhythm, 2008,5 : s12.
  • 2Schnfieder RE, Hilgers KF, Schlaich MP, et al. Renin-angiotensin system and cardiovascular risk [ J ]. Lancet,2007,369 : 1 208.
  • 3Schneider MP, Hua TA, Bohm M, et al. Prevention of atrial fibril- lation by renin-angiotensin system inhibition: a meta-analysis[ J ]. J Am Coil Cardiol,2010,55:2 299.
  • 4向晋涛,朱刚艳,江洪.抑制血管紧张素系统降低心房颤动的发生:临床和实验的证据[J].中国心脏起搏与心电生理杂志,2009,23(5):382-385. 被引量:25
  • 5Schlaich MP, Sobotka PA, Krum H, et al. Renal sympathetic-nerveablation for uncontrolled hypertension [ J]. N Engl J Med, 2009, 361 : 932.
  • 6Zhao Q, Yu s, Zou M, et al. Effect of renal sympathetic denerva- tion on the inducibility of atrial fibrillation during rapid atrial pacing [J]. J Interv Card Electrophysiol,2012,35(2) : 119.
  • 7Krum H, Schlaich M, Whitbourn R, et al. Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study[ J]. Lancet,2009,373:1 275.
  • 8Esler M, Krum H, Sobotka PA, et al. Renal sympathetic denerva- tion in patients with treatment-resistant hypertension (The Symplici- ty HTN-2 Trial) : a randomised controlled trial [ J ]. Lancet,2010, 373:1 903.
  • 9汪强,单其俊.经皮肾去交感神经导管射频消融术的临床研究进展[J].中国心脏起搏与心电生理杂志,2012,26(6):471-475. 被引量:12
  • 10Stambler BS, Guo GB. Atrial natriuretic peptide has dose-depend- ent, autonomically mediated effects on atrial refractoriness and repo- larization in anesthetized dogs [ J ]. J Cardiovase Electrophysiol,2005,16:1 341.

二级参考文献52

  • 1刘英明,朱智明,曹毅,李贤峰,高连如,杨晔,卢才义,王士雯.阻断肾素-血管紧张素系统对高血压患者心房颤动发生危险的影响[J].中国心脏起搏与心电生理杂志,2005,19(4):264-266. 被引量:22
  • 2张家明,李大强,于世龙,冯义柏,胡还忠.坎地沙坦对家兔快速心房刺激所致缝隙连接蛋白40重构的影响[J].中国心脏起搏与心电生理杂志,2005,19(5):385-387. 被引量:13
  • 3李晓东,王建春,苏秀珍,刘军,谢晨,蒋文平.贝那普利和洛沙坦对老年冠心病患者阵发性心房颤动的影响[J].中国心脏起搏与心电生理杂志,2006,20(5):413-415. 被引量:4
  • 4代建军,李广平,李健,许纲,杨万松,王静,程晓丹.Ang-(1-7)及AngⅡ对犬心房肌细胞外向钾通道电流的作用[J].中国心脏起搏与心电生理杂志,2007,21(1):63-66. 被引量:3
  • 5L'Allier PL, Ducharme A, Keller PF, et al. Angiotensin converting enzyme inhibition in hypertensive patients is associated with a reduction in the occurrence of atrial fibrillation [ J ]. J Am Coll Cardiol, 2004,44:159.
  • 6Wachtell K, Lehto M, Gerdts E, et al. Angiotensin-Ⅱ receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol: the Losartan Intervention For End Point Reduction in Hypertension (LIFE) study [ J ]. J Am Coll Cardiol, 2005,45:712.
  • 7Pedersen OD, Bagger H, Kober L, et al. Trandopril reduces the incidence of atrial fibrillation after acute myocardial infarction in patients with left ventricular dysfunction [ J ]. Circulation, 1999, 100 : 376.
  • 8Vermes E, Tardif JC, Bourassa MG, et al. Enalapril decreases the incidence of atrial fibrillation in patients with left ventricular dysfunction: insight from the studies of left ventricular dysfunction (SOLVD) trials [J]. Circulation,2003,107:2 926.
  • 9Alsheikh-Ali AA, Wang PJ, Rand W,et al. Enalapril treatment and hospitalization with atrial tachyarrhythmias in patients with left ventricular dysfunction [ J ]. Am Heart J, 2004,147 : 1 061.
  • 10Maggioni AP, Latini R, Carson PE,et al. Valsartan reduces the incidence of atrial fibrillation in patients with heart faiture: results from the Valsartan Heart Failure Trial (Val-HeFT) [ J]. Am Heart J ,2005,149:548.

共引文献37

同被引文献84

引证文献22

二级引证文献511

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部